Prevalence of fatty liver disease and its risk factors in the population of South China. - Wikidata - awgldk - TriplyDB

Prevalence of fatty liver disease and its risk factors in the population of South China.

Prevalence of fatty liver disease and its risk factors in the population of South China.

http://www.wikidata.org/entity/Q34382961

about

Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet Neck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver disease Prevalence of fatty liver disease and the economy in China: A systematic review Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Sonographic assessment of fatty liver: intraobserver and interobserver variability.Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, Iran NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital.The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.Nonalcoholic fatty liver disease and aging: epidemiology to management.Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.The effect of miRNA-122 in regulating fat deposition in a cell line model.Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway.Cholecystectomy does not significantly increase the risk of fatty liver disease Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population.Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study.PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese.Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China.An exploration of prevalence and associated factors of nonalcoholic Fatty liver disease in the taiwanese police service.An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case-control study Non alcoholic fatty liver disease in southern Iran: a population based study.Association between metabolic syndrome and the development of non-alcoholic fatty liver disease Prevalence and features of fatty liver detected by physical examination in Guangzhou.Rural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD.Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?Relationship between Methyl Tertiary Butyl Ether Exposure and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Petrol Station Attendants in Southern China.Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease.Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.Prevalence of Nonalcoholic Fatty Liver Disease and Economy.Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China.

P2860

Q26822513-01F98DD1-707F-4AE2-85D3-CC93F54FB64A Q28354293-1F4B7A71-A569-4E37-B1E8-7534FE579ED4 Q28543519-9E9D98DC-4DDB-4CD8-990B-24400E43DC59 Q28647695-05AC2CBB-6A8B-46B3-98F2-B480B8B08513 Q30389752-71879DB3-E0D7-4022-B6F7-B65B07657C6F Q30419242-4D0D34B7-65F4-4E72-BA2B-CC7B6BAD4D40 Q33630744-64356F82-72AF-45D2-A42A-D764F4CF4219 Q33844463-FB8DCB09-BB76-4CAF-A860-D6204900E66A Q34005976-4F06C1A2-C224-4464-88FF-44381F05E3B2 Q34019843-50E253A0-682A-44C4-BCF8-E61CBE6ED2C0 Q34091040-6750959F-3006-43A5-9FD1-E12BD2B16539 Q34366861-52D82014-2B03-4A73-8CE7-92143BB126BC Q34415002-1C38FB5E-FB29-4463-A4BF-2806AD4BD67A Q34501554-1EF205F7-40C5-47E1-956C-1CB09DC5CF34 Q34709831-ECFD28F8-A245-4EC6-A28E-B22950698233 Q35045813-3852973A-3329-4319-A152-7110DC966444 Q35056293-D647FFA8-65AA-4DCD-AB10-2402B967FF80 Q35150742-6266C008-90FB-4ABE-8B33-E799246A5FC8 Q35221820-080932EB-FBDA-44CD-9926-D7528EC78C03 Q35674288-D4381AEC-35A5-478C-87FA-D440A7351D92 Q35741199-C9D5F5B0-019E-41C4-898F-0C9645AB2943 Q35766755-6B24183F-AA70-4FA7-A851-D19777D49956 Q35916575-8D41E60C-0F31-4001-BE1C-65B5F31CF608 Q35927767-0A522014-2C25-4589-8F7E-C3F46B55F1C2 Q36131261-72A2D71F-6982-4903-95DA-2C533B201981 Q36349054-8C90EBF1-DC0A-451A-BB9A-B4B89B2DE8C8 Q36405031-B4F69E21-D8F9-4344-9FA9-222DF60A122D Q36450465-401CFAAF-8969-43CB-B823-2003E749E303 Q36608652-E2624D06-D4A0-47D7-8EA7-0F22FF8D192E Q37073854-1C1F5381-1C1F-4015-86D2-2A67ED9BDABC Q37075582-6C663D50-C249-40B9-9C18-131664BB4FB3 Q37118863-17D02C34-A024-424F-B1BD-C1B7F50F7983 Q37246601-3BC90164-6FEA-4DB2-AF08-9518BDDA8553 Q37317465-0ADEBDED-4442-409C-AF80-76DA8C6031EF Q37379009-E7E42E18-7A92-4B03-BB41-1F10DC5B0CD4 Q37397018-5C36DE89-E7A6-457F-9F59-BC163D4D7B02 Q37658856-17F65502-8ABA-432A-9C96-4B2432562CF6 Q37682543-C98DAA61-22DA-4402-8B69-DE9EB5B4C1DA Q38504843-3CA35039-6984-4430-99BD-D02B6B5410D5 Q38740810-DD5082BE-34CD-4CBE-9CEA-6BE6690D772B

P2860

Prevalence of fatty liver disease and its risk factors in the population of South China.

http://www.wikidata.org/entity/Q34382961

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Prevalence of fatty liver disease and its risk factors in the population of South China.

@ast

Prevalence of fatty liver disease and its risk factors in the population of South China.

@en

Prevalence of fatty liver disease and its risk factors in the population of South China.

@nl

type

label

Prevalence of fatty liver disease and its risk factors in the population of South China.

@ast

Prevalence of fatty liver disease and its risk factors in the population of South China.

@en

Prevalence of fatty liver disease and its risk factors in the population of South China.

@nl

prefLabel

Prevalence of fatty liver disease and its risk factors in the population of South China.

@ast

Prevalence of fatty liver disease and its risk factors in the population of South China.

@en

Prevalence of fatty liver disease and its risk factors in the population of South China.

@nl

P1433

Q34382961-EE0B38EB-BCB9-48BA-ADDC-B7ACFCD02027

P1476

Q34382961-39CCFCE2-1AD9-47A3-8148-C2BA2E96FEC0

P2093

Q34382961-6DF195C6-1B7C-482D-A14B-A9DB0D24C0BF

Q34382961-74FDD9B7-520D-4475-AF0F-EF3F1A14CD20

Q34382961-75E006B3-2ACE-4AF5-8938-F198EF2C5D8A

Q34382961-7BBC7052-DF98-4D4A-A7BE-13F7EF31C64A

Q34382961-8E545F68-AF7A-44C6-A8AB-CD1A7BF7850D

Q34382961-9573D967-587F-42BB-AE53-0626A89A25F7

Q34382961-A1E13272-A2BC-4668-AA73-EF3A5C2E0198

Q34382961-F123EEB0-7F08-4E87-BB0F-085ECAA8DA18

P2860

Q34382961-15820D29-F8A6-4E4B-94E0-B965C30AA5A4

Q34382961-240D2204-8607-4288-BA2A-67CF238BEED0

Q34382961-349B7BFD-F4B6-4B31-A68B-B4AFBB29D20B

Q34382961-40D97F34-0791-487C-98AC-B2DABC1E5E8A

Q34382961-4CD787C0-677F-4B78-AE3A-F62175B3F97E

Q34382961-4E5A4EEC-0D1A-4A53-B888-5B24072F5FFD

Q34382961-60F9EB77-B0E3-4997-92B2-AC3E0542C1F8

Q34382961-7A85E9A9-6C5A-489C-8999-B15F353050F4

Q34382961-86EB6961-339E-4A8A-BC7C-1553D9611BA8

Q34382961-9027D58B-605F-40E0-82F9-C22003A72272

P304

Q34382961-07067F76-1D7C-4BD2-B916-7567F288C2C2

P31

Q34382961-A2388DF1-DA2D-461B-A1C4-2AB71F95632A

P356

Q34382961-49A3681C-DCDD-45CF-B47C-C14F1EDCF0DF

P407

Q34382961-FCAF29F9-AA31-4194-9A02-F4E3622A54CE

P433

Q34382961-67B34639-400B-4C44-92CE-48DEC3DE87B1

P478

Q34382961-D60D821C-7BB7-493E-8B0F-5AE5A1A3DEF6

P577

Q34382961-8E612131-FF92-4D34-ACC9-D10C7E702326

P5875

Q34382961-9954C82C-0B60-4FD1-B86D-EF77528722B4

P698

Q34382961-E587E43D-3C6F-44BD-AEB0-4C6FC8721863

P932

Q34382961-468E0A2D-91F3-4EAA-B612-5190E0A81305

P356

WJG.V13.I47.6419

P1433

World Journal of Gastroenterology

P1476

Prevalence of fatty liver disease and its risk factors in the population of South China.

@en

P2093

Jin-Xiang Ma

http://www.w3.org/2001/XMLSchema#string

Lun-Gen Lu

http://www.w3.org/2001/XMLSchema#string

Min-Hu Chen

http://www.w3.org/2001/XMLSchema#string

Pin-Jin Hu

http://www.w3.org/2001/XMLSchema#string

Sheng-Li Shi

http://www.w3.org/2001/XMLSchema#string

Yong-Jian Zhou

http://www.w3.org/2001/XMLSchema#string

Yu-Qiang Nie

http://www.w3.org/2001/XMLSchema#string

Yu-Yuan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemic obesity and type 2 diabetes in Asia

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Nonalcoholic fatty liver disease

Global challenges in liver disease.

The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers.

Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.

Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Epidemiology of nonalcoholic fatty liver.

P304

6419-6424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I47.6419

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5767840

http://www.w3.org/2001/XMLSchema#string

P698

18081233

http://www.w3.org/2001/XMLSchema#string

P932

4205463

http://www.w3.org/2001/XMLSchema#string